Selective adenosine A2A receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma

T. Genovese, A. Melani, E. Esposito, I. Paterniti, E. Mazzon, R. Di Paola, P. Bramanti, J. Linden, F. Pedata, Salvatorre Cuzzocrea

Research output: Contribution to journalArticle

Abstract

Adenosine is an important regulator of inflammatory mechanisms. Functional studies indicate a protective effect of adenosine A2A receptor agonists in spinal cord injury (SCI). The basic molecular mechanisms accounting for their protective effects from spinal cord injury have to be fully elucidated. The aim of this study is to evaluate in vivo protection by two selective A2A receptor agonists, 2-[p-(2-carboxyethyl) phenylethylamino]-50-ethylcarboxamidoadenosine (CGS 21680, 100 μg/kg) and (4-[3-(6-amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxytetrahydro-furan-2-yl) -9H-purin-2-yl)prop-2-ynyl] piperidine-1-carboxylic acid methyl ester) (ATL 313, 3 μg/kg) on the degree of apoptosis, in the experimental model of spinal cord injury. Spinal cord trauma was induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord trauma in mice was characterised by edema, neutrophilic infiltration and apoptosis. ATL 313, administered by subcutaneously implanted osmotic minipumps after SCI, clearly reduced motor deficit for up to 19 days after operation. The selective A2A receptor agonists ATL 313 and CGS 21680 administered after SCI, reduced tissue damage, TUNEL staining, cytokine (TNF-α) expression, Bax, Fas-L and Caspase-3 expression, Annexin-V staining, while increasing Bcl-2 expression. In conclusion, our results demonstrate that treatment with adenosine A2A receptor agonists prevents the apoptotic process that is an important step of secondary damage after SCI.

Original languageEnglish
Pages (from-to)73-86
Number of pages14
JournalJournal of Biological Regulators and Homeostatic Agents
Volume24
Issue number1
Publication statusPublished - Jan 2010

Fingerprint

Adenosine A2 Receptor Agonists
Spinal Cord Injuries
Theoretical Models
Apoptosis
Staining and Labeling
Laminectomy
Annexin A5
In Situ Nick-End Labeling
Carboxylic Acids
Surgical Instruments
Caspase 3
Adenosine
Blood Vessels
Edema
Esters
Cytokines

Keywords

  • Adenosine A receptor CGS 21680
  • ATL 313
  • SCI

ASJC Scopus subject areas

  • Oncology
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)
  • Immunology and Allergy
  • Immunology
  • Endocrinology
  • Physiology
  • Cancer Research

Cite this

Selective adenosine A2A receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma. / Genovese, T.; Melani, A.; Esposito, E.; Paterniti, I.; Mazzon, E.; Di Paola, R.; Bramanti, P.; Linden, J.; Pedata, F.; Cuzzocrea, Salvatorre.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 24, No. 1, 01.2010, p. 73-86.

Research output: Contribution to journalArticle

Genovese, T, Melani, A, Esposito, E, Paterniti, I, Mazzon, E, Di Paola, R, Bramanti, P, Linden, J, Pedata, F & Cuzzocrea, S 2010, 'Selective adenosine A2A receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma', Journal of Biological Regulators and Homeostatic Agents, vol. 24, no. 1, pp. 73-86.
Genovese, T. ; Melani, A. ; Esposito, E. ; Paterniti, I. ; Mazzon, E. ; Di Paola, R. ; Bramanti, P. ; Linden, J. ; Pedata, F. ; Cuzzocrea, Salvatorre. / Selective adenosine A2A receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma. In: Journal of Biological Regulators and Homeostatic Agents. 2010 ; Vol. 24, No. 1. pp. 73-86.
@article{3027306c789b4202956be6c312968a50,
title = "Selective adenosine A2A receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma",
abstract = "Adenosine is an important regulator of inflammatory mechanisms. Functional studies indicate a protective effect of adenosine A2A receptor agonists in spinal cord injury (SCI). The basic molecular mechanisms accounting for their protective effects from spinal cord injury have to be fully elucidated. The aim of this study is to evaluate in vivo protection by two selective A2A receptor agonists, 2-[p-(2-carboxyethyl) phenylethylamino]-50-ethylcarboxamidoadenosine (CGS 21680, 100 μg/kg) and (4-[3-(6-amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxytetrahydro-furan-2-yl) -9H-purin-2-yl)prop-2-ynyl] piperidine-1-carboxylic acid methyl ester) (ATL 313, 3 μg/kg) on the degree of apoptosis, in the experimental model of spinal cord injury. Spinal cord trauma was induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord trauma in mice was characterised by edema, neutrophilic infiltration and apoptosis. ATL 313, administered by subcutaneously implanted osmotic minipumps after SCI, clearly reduced motor deficit for up to 19 days after operation. The selective A2A receptor agonists ATL 313 and CGS 21680 administered after SCI, reduced tissue damage, TUNEL staining, cytokine (TNF-α) expression, Bax, Fas-L and Caspase-3 expression, Annexin-V staining, while increasing Bcl-2 expression. In conclusion, our results demonstrate that treatment with adenosine A2A receptor agonists prevents the apoptotic process that is an important step of secondary damage after SCI.",
keywords = "Adenosine A receptor CGS 21680, ATL 313, SCI",
author = "T. Genovese and A. Melani and E. Esposito and I. Paterniti and E. Mazzon and {Di Paola}, R. and P. Bramanti and J. Linden and F. Pedata and Salvatorre Cuzzocrea",
year = "2010",
month = "1",
language = "English",
volume = "24",
pages = "73--86",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "1",

}

TY - JOUR

T1 - Selective adenosine A2A receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma

AU - Genovese, T.

AU - Melani, A.

AU - Esposito, E.

AU - Paterniti, I.

AU - Mazzon, E.

AU - Di Paola, R.

AU - Bramanti, P.

AU - Linden, J.

AU - Pedata, F.

AU - Cuzzocrea, Salvatorre

PY - 2010/1

Y1 - 2010/1

N2 - Adenosine is an important regulator of inflammatory mechanisms. Functional studies indicate a protective effect of adenosine A2A receptor agonists in spinal cord injury (SCI). The basic molecular mechanisms accounting for their protective effects from spinal cord injury have to be fully elucidated. The aim of this study is to evaluate in vivo protection by two selective A2A receptor agonists, 2-[p-(2-carboxyethyl) phenylethylamino]-50-ethylcarboxamidoadenosine (CGS 21680, 100 μg/kg) and (4-[3-(6-amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxytetrahydro-furan-2-yl) -9H-purin-2-yl)prop-2-ynyl] piperidine-1-carboxylic acid methyl ester) (ATL 313, 3 μg/kg) on the degree of apoptosis, in the experimental model of spinal cord injury. Spinal cord trauma was induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord trauma in mice was characterised by edema, neutrophilic infiltration and apoptosis. ATL 313, administered by subcutaneously implanted osmotic minipumps after SCI, clearly reduced motor deficit for up to 19 days after operation. The selective A2A receptor agonists ATL 313 and CGS 21680 administered after SCI, reduced tissue damage, TUNEL staining, cytokine (TNF-α) expression, Bax, Fas-L and Caspase-3 expression, Annexin-V staining, while increasing Bcl-2 expression. In conclusion, our results demonstrate that treatment with adenosine A2A receptor agonists prevents the apoptotic process that is an important step of secondary damage after SCI.

AB - Adenosine is an important regulator of inflammatory mechanisms. Functional studies indicate a protective effect of adenosine A2A receptor agonists in spinal cord injury (SCI). The basic molecular mechanisms accounting for their protective effects from spinal cord injury have to be fully elucidated. The aim of this study is to evaluate in vivo protection by two selective A2A receptor agonists, 2-[p-(2-carboxyethyl) phenylethylamino]-50-ethylcarboxamidoadenosine (CGS 21680, 100 μg/kg) and (4-[3-(6-amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxytetrahydro-furan-2-yl) -9H-purin-2-yl)prop-2-ynyl] piperidine-1-carboxylic acid methyl ester) (ATL 313, 3 μg/kg) on the degree of apoptosis, in the experimental model of spinal cord injury. Spinal cord trauma was induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord trauma in mice was characterised by edema, neutrophilic infiltration and apoptosis. ATL 313, administered by subcutaneously implanted osmotic minipumps after SCI, clearly reduced motor deficit for up to 19 days after operation. The selective A2A receptor agonists ATL 313 and CGS 21680 administered after SCI, reduced tissue damage, TUNEL staining, cytokine (TNF-α) expression, Bax, Fas-L and Caspase-3 expression, Annexin-V staining, while increasing Bcl-2 expression. In conclusion, our results demonstrate that treatment with adenosine A2A receptor agonists prevents the apoptotic process that is an important step of secondary damage after SCI.

KW - Adenosine A receptor CGS 21680

KW - ATL 313

KW - SCI

UR - http://www.scopus.com/inward/record.url?scp=77953722078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953722078&partnerID=8YFLogxK

M3 - Article

C2 - 20385073

AN - SCOPUS:77953722078

VL - 24

SP - 73

EP - 86

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 1

ER -